B
Biolight Life Sciences Ltd
TASE:BOLT
Biolight Life Sciences Ltd
TASE:BOLT
Price:
336.6
ILS
-7.02%
Market Closed
Market Cap:
₪30.5m
Balance Sheet
Balance Sheet Decomposition
Biolight Life Sciences Ltd
Biolight Life Sciences Ltd
Balance Sheet Decomposition is not available for
Biolight Life Sciences Ltd
Biolight Life Sciences Ltd
Balance Sheet
Biolight Life Sciences Ltd
Biolight Life Sciences Ltd
Currency: ILS
| Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||
| Cash & Cash Equivalents |
2
|
5
|
30
|
14
|
10
|
4
|
1
|
1
|
18
|
22
|
51
|
25
|
15
|
43
|
35
|
30
|
33
|
13
|
5
|
10
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
4
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
2
|
5
|
30
|
14
|
10
|
0
|
0
|
0
|
18
|
22
|
51
|
25
|
15
|
43
|
35
|
30
|
33
|
13
|
5
|
10
|
|
| Short-Term Investments |
17
|
11
|
13
|
7
|
11
|
3
|
11
|
28
|
0
|
6
|
0
|
0
|
0
|
0
|
5
|
21
|
0
|
4
|
3
|
4
|
|
| Total Receivables |
0
|
3
|
2
|
1
|
1
|
1
|
0
|
1
|
2
|
1
|
1
|
2
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
28
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
19
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
20
|
47
|
45
|
22
|
21
|
8
|
12
|
31
|
21
|
32
|
53
|
30
|
20
|
63
|
41
|
51
|
34
|
18
|
9
|
14
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
3
|
3
|
3
|
4
|
4
|
|
| PP&E Gross |
0
|
0
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
7
|
7
|
4
|
4
|
0
|
4
|
0
|
0
|
1
|
1
|
1
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
10
|
8
|
0
|
0
|
0
|
0
|
0
|
19
|
29
|
10
|
26
|
35
|
19
|
14
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
2
|
0
|
0
|
5
|
1
|
0
|
1
|
0
|
0
|
1
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
20
N/A
|
48
+136%
|
46
-4%
|
23
-51%
|
22
0%
|
10
-55%
|
30
+192%
|
42
+41%
|
34
-18%
|
40
+18%
|
63
+56%
|
35
-44%
|
25
-30%
|
90
+265%
|
75
-17%
|
65
-14%
|
64
-1%
|
57
-11%
|
33
-41%
|
34
+2%
|
|
| Liabilities | |||||||||||||||||||||
| Accounts Payable |
2
|
2
|
3
|
2
|
4
|
3
|
2
|
0
|
1
|
1
|
7
|
7
|
7
|
1
|
3
|
2
|
2
|
2
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
2
|
2
|
3
|
2
|
4
|
4
|
4
|
2
|
5
|
7
|
7
|
7
|
7
|
5
|
4
|
3
|
2
|
3
|
2
|
2
|
|
| Long-Term Debt |
0
|
28
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
7
|
8
|
8
|
1
|
1
|
10
|
3
|
12
|
6
|
2
|
5
|
1
|
1
|
1
|
1
|
1
|
4
|
|
| Other Liabilities |
1
|
10
|
12
|
1
|
6
|
4
|
3
|
3
|
7
|
8
|
10
|
12
|
9
|
5
|
2
|
1
|
1
|
1
|
1
|
1
|
|
| Total Liabilities |
3
N/A
|
40
+1 393%
|
14
-64%
|
10
-30%
|
18
+73%
|
16
-11%
|
7
-57%
|
4
-47%
|
22
+503%
|
12
-45%
|
29
+138%
|
24
-15%
|
19
-24%
|
8
-57%
|
6
-23%
|
6
-8%
|
3
-38%
|
4
+11%
|
4
-4%
|
7
+97%
|
|
| Equity | |||||||||||||||||||||
| Common Stock |
0
|
0
|
1
|
1
|
1
|
1
|
2
|
3
|
3
|
0
|
7
|
0
|
0
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
28
|
58
|
73
|
96
|
115
|
110
|
123
|
149
|
166
|
187
|
231
|
249
|
173
|
196
|
209
|
209
|
217
|
243
|
250
|
|
| Additional Paid In Capital |
18
|
31
|
85
|
88
|
103
|
112
|
135
|
161
|
162
|
0
|
219
|
0
|
0
|
248
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
5
|
4
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
242
|
255
|
4
|
265
|
269
|
270
|
270
|
273
|
277
|
|
| Total Equity |
18
N/A
|
8
-55%
|
32
+295%
|
12
-61%
|
5
-60%
|
5
N/A
|
23
N/A
|
38
+67%
|
13
-67%
|
28
+126%
|
35
+22%
|
11
-69%
|
6
-44%
|
82
+1 250%
|
69
-16%
|
59
-14%
|
61
+3%
|
53
-12%
|
30
-44%
|
27
-10%
|
|
| Total Liabilities & Equity |
20
N/A
|
48
+136%
|
46
-4%
|
23
-51%
|
22
0%
|
10
-55%
|
30
+192%
|
42
+41%
|
34
-18%
|
40
+18%
|
63
+56%
|
35
-44%
|
25
-30%
|
90
+265%
|
75
-17%
|
65
-14%
|
64
-1%
|
57
-11%
|
33
-41%
|
34
+2%
|
|
| Shares Outstanding | |||||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
3
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|
Switch to:
Switch to:
See Also
Discover More
